Sugiyama S - Search Results

1

[Basic study for immunoscintigraphy of ovarian cancer using 99mTc labeled F(ab')2 fragments of monoclonal antibody].

Sugiyama S. Sugiyama S. Kaku Igaku. 1994 Apr;31(4):327-36. Kaku Igaku. 1994. PMID: 8196229 Japanese.

2

Radioimmunoscintigraphy of colorectal cancer with technetium-99m-labeled murine anti-carcinoembryonic antigen monoclonal antibody in athymic nude mice.

Watanabe N, Oriuchi N, Sugiyama S, Kuroki M, Matsuoka Y. Watanabe N, et al. Among authors: sugiyama s. Ann Nucl Med. 1994 Feb;8(1):23-30. doi: 10.1007/BF03164983. Ann Nucl Med. 1994. PMID: 8204394

3

[Experimental study of tumor detection using 131I-labeled F (ab)2 fragments of monoclonal antibodies to CA 19-9 and CEA (IMACIS-1)].

Mitsuhashi N, Kazumoto T, Nakayama Y, Sugiyama S, Yamakawa M, Yonome I, Nakamura Y, Nagai T, Niibe H. Mitsuhashi N, et al. Among authors: sugiyama s. Gan No Rinsho. 1989 Dec;35(15):1753-8. Gan No Rinsho. 1989. PMID: 2691716 Japanese.

4

Different biodistribution of 99mTc-labelled chimeric mouse-human monoclonal antibody between athymic mice model and human.

Oriuchi N, Watanabe N, Sugiyama S, Higuchi T, Imai K, Yamanaka H, Hashimoto M, Kanda H, Endo K. Oriuchi N, et al. Among authors: sugiyama s. Br J Cancer. 1996 Jun;73(12):1466-72. doi: 10.1038/bjc.1996.278. Br J Cancer. 1996. PMID: 8664114 Free PMC article. Clinical Trial.

5

Antibody-dependent difference in biodistribution of monoclonal antibodies in animal models and humans.

Oriuchi N, Watanabe N, Kanda H, Hashimoto M, Sugiyama S, Takenoshita S, Imai K, Ueda R, Endo K. Oriuchi N, et al. Among authors: sugiyama s. Cancer Immunol Immunother. 1998 Aug;46(6):311-7. doi: 10.1007/s002620050492. Cancer Immunol Immunother. 1998. PMID: 9756415 Free PMC article.

6

In vitro and in vivo comparison of binding of 99m-Tc-labeled anti-CEA MAb F33-104 with 99m-Tc-labeled anti-CEA MAb BW431/26.

Watanabe N, Oriuchi N, Sugiyama S, Kuroki M, Matsuoka Y, Tanada S, Murata H, Inoue T, Sasaki Y. Watanabe N, et al. Among authors: sugiyama s. Nuklearmedizin. 1999;38(4):115-9. Nuklearmedizin. 1999. PMID: 10392376

7

[The clinical evaluation of serum CA 19-9 and CA 125 levels in patients with malignant tumors. Comparison with serum CEA levels].

Mitsuhashi N, Niibe H, Yamakawa M, Sugiyama S, Mitomo O, Katoh S, Nagai T. Mitsuhashi N, et al. Among authors: sugiyama s. Kaku Igaku. 1985 Dec;22(12):1835-41. Kaku Igaku. 1985. PMID: 3868729 Japanese. No abstract available.

8

Semiquantitative SPECT tumor uptake of technetium-99m-labeled anti-CEA monoclonal antibody in colorectal tumor.

Oriuchi N, Endo K, Watanabe N, Sugiyama S, Asao T, Takenoshita S, Nagamachi Y, Baum RP. Oriuchi N, et al. Among authors: sugiyama s. J Nucl Med. 1995 Apr;36(4):679-83. J Nucl Med. 1995. PMID: 7699464 Free article.

9

[Development and application of a program reformatting arbitrary axis tomograms in single photon emission CT].

Mishio K, Nakajima T, Sugiyama S, Watanabe Y, Matsukawa S, Sakura M. Mishio K, et al. Among authors: sugiyama s. Kaku Igaku. 1982 Apr;19(3):507-11. Kaku Igaku. 1982. PMID: 6982360 Japanese. No abstract available.

10

Induction of irreversible glomerulosclerosis in the rat by repeated injections of a monoclonal anti-Thy-1.1 antibody.

Morita H, Maeda K, Obayashi M, Shinzato T, Nakayama A, Fujita Y, Takai I, Kobayakawa H, Inoue I, Sugiyama S, et al. Morita H, et al. Among authors: sugiyama s. Nephron. 1992;60(1):92-9. doi: 10.1159/000186711. Nephron. 1992. PMID: 1738421

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,621 results

Search Page

Filters